FridaySep 10, 2021 9:15 am

DSG Global Inc. (DSGT) Subsidiary Announces Launch of Innovative Three-Wheel, Four-Passenger EV

New Sagitta electric vehicle will be unveiled at Nov. 17 LA Auto Show Imperium is CMW’s primary Sagitta distribution partner; company anticipates high demand for game-changing vehicle Limited production planned by late 2022, reservations accepted mid-year DSG Global (OTCQB: DSGT) and its subsidiary, Imperium Motors, have announced the planned unveiling of the Sagitta(TM) electric vehicle during the upcoming Nov. 17, 2021, LA Auto Show (https://ibn.fm/3R6GE). Imperium will partner with California Mobility Works (“CMW”) to show the new three-wheel, four-passenger EV, which is expected to create quite a stir during the shows.   “We are thrilled to team up with CMW and make…

Continue Reading

FridaySep 10, 2021 9:15 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Marks Impressive Performance for Q2 2021

$58.5 million in Adjusted Sales for first six months of 2021 The company also reported repaying approximately $18 million of debt and restructuring over $20 million into a long-term debt Q2 also marked RWB’s acquisition of Acreage Florida, as well as an operational 45,000 SF greenhouse within the state, which it projects, will begin harvesting in Q4 2021 RWB’s CEO expressed his optimism about the company’s performance in the Q3 and the second half of the year, given the strides made and the momentum realized in Q2  On August 30, Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) released…

Continue Reading

FridaySep 10, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) CEO Discusses Psychedelics, Company’s Progress, Plans, Business in a Recent Bell2Bell Podcast Interview

Mind Cure Health Inc. CEO Kelsey Ramsden was featured in a recent Bell2Bell podcast interview, during which she explained the company’s primary focal points – digital therapeutics and drug development On the digital therapeutics side of its business, the company is developing iSTRYM, a clinical-grade, evidence-backed, science-based, AI-driven tool for both therapists and patients, scheduled for full commercial launch in Q1 2022 MCUR has successfully synthesized the chemically complex ibogaine and intends to scale up its production during the remainder of 2021 As a diversified life sciences company at the forefront of the mental health industry, Mind Cure Health (CSE:…

Continue Reading

FridaySep 10, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Publishes Report Outlining Cannabis Treatments for Conditions Associated with HIV and AIDS

RYAH releases report outlining ways cannabis is being used to treat conditions associated with HIV and AIDS Report data compiled by RYAH Data Ecosystem between January 1, 2018, and August 26, 2021 Data includes specific HIV and AIDS conditions, details cannabis strains used by patients  Three-part RYAH Data Ecosystem includes volume control and management devices, QR tracking to identify product formulations and parameters, mobile apps to manage information and provide feedback With a mission to advance remote-health solutions and analytics-based patient treatments across the world, RYAH Group (CSE: RYAH) (formerly RYAH Medtech) is the leader in volume control and management…

Continue Reading

FridaySep 10, 2021 9:00 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Strengthens its Board with Fred Leigh’s Appointment as Executive Chairman

On September 7, 2021, Mr. Fred Leigh was appointed as director and Executive Chairman of PlantX’s Board of Directors, effective immediately Mr. Leigh previously chaired the company’s Advisory Board, which has since been dissolved PlantX looks forward to leveraging on Mr. Leigh’s expertise, knowledge and over 40 years of experience in capital markets to help steer the company Mr. Leigh’s appointment follows PlantX’s move to expand its market reach and grow its overall market presence On September 7, 2021, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) announced the appointment of Mr. Fred Leigh as a director and Executive Chairman…

Continue Reading

ThursdaySep 09, 2021 1:36 pm

Data Services Innovator FingerMotion Inc. (FNGR) Sees Growing Potential in China’s Insurance Market

U.S.-based data tech company FingerMotion is focused on the market potential of Chinese companies’ need for rich communication services (“RCS”) and big-data insights FingerMotion has been particularly focused on the insurance industry’s need for data analysis in recent months, particularly in light of China’s early-stage structure for credit and risk assessment among consumers FingerMotion’s Sapientus platform provides predictive services for risk assessment, spawning a landmark agreement with Pacific Life Re-insurance’s insurtech solutions in China Because China regards insurance as compulsory for sectors such as pension protection, medical care, job hazards, unemployment and maternity care, the potential for insurance services is…

Continue Reading

ThursdaySep 09, 2021 1:19 pm

Flora Growth Corp. (NASDAQ: FLGC) Inks €2M Investment in Hoshi As Part of its European Expansion Plan

Flora closed a €2 million investment in Hoshi International Inc., fulfilling the earlier-announced LOI back in June 2021 This move is set to capitalize on Hoshi’s strong European presence, its technical know-how along with its understanding of the European market Hoshi acknowledged the investment with the announcement that it would work together with Flora to bring to market finished product formats from Flora’s brand portfolio Flora referred to this investment as the first of many steps by the company to advance its plans to launch products across the world On August 24, 2021, Flora Growth (NASDAQ: FLGC) announced closing a…

Continue Reading

ThursdaySep 09, 2021 1:00 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announced as Participant at H.C. Wainwright Global Investment Conference

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, will be featured at this year’s 23rd annual H.C. Wainwright Global Investment Conference. The three-day, virtual conference is scheduled for Sept. 13–15, 2021. WTER president and CEO Ricky Wright will present during the conference; his presentation will be available beginning Sept. 13. Wright’s presentation will include a look at the company’s most recent highlights and accomplishments as well as a discussion regarding WTER’s future strategy and outlook. In addition, members of the company’s management team will also be available for virtual meetings with qualified investors attending…

Continue Reading

ThursdaySep 09, 2021 12:09 pm

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Nominated in Best and Brightest in Medical Imaging Award Campaign

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) is commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers. The company has announced its receipt of a semifinalist nomination for AuntMinnie.com's 2021 award campaign to recognize the best and brightest in medical imaging. According to the update, Auntminnie.com, a leading radiology news website, has recognized Izotropic's IzoView Breast CT System in the Best New Radiology Device category. The company congratulates all other nominees and thanks all of those who have and continue to work on IzoView, attributing this nomination to a…

Continue Reading

ThursdaySep 09, 2021 12:08 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) to Address Advances in its Bioavailability Technology DehydraTECH(TM) at Wainwright Life Sciences Conference

Drug delivery technology innovator Lexaria Bioscience is celebrating the positive outcomes of clinical testing of its trademarked DehydraTECH platform for reducing the blood stream delivery time of anti-virals, NSAIDS and potential hypertension treatments Lexaria will participate in H.C. Wainwright’s annual Global Investor Conference this month to help bring further attention to its successes The DehydraTECH technology enhances the delivery of pharmaceuticals that can be administered orally, and testing has shown no adverse chemical compounds have been created in the process The COVID-19 pandemic has raised the profile of the anti-viral medication market, enhancing the opportunities for Lexaria’s revenue stream As…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered